Speakers
Prof. Justin Bishop
Professor Justin Bishop is Chair in Pathology and Professor and Chief of Anatomic Pathology at UT Southwestern Medical Center, where he specialises in the surgical pathology diagnosis of head and neck and endocrine diseases. He has published more than 250 journal articles, 35 book chapters, and nine books, and has lectured extensively both nationally and internationally.
He served as an editor for the most recent WHO Classification of Head and Neck Tumors and was the lead author of the AFIP Fascicle of Salivary Gland Tumors. He currently serves as Editor-in-Chief of Seminars in Diagnostic Pathology, Associate Editor for Modern Pathology and JAMA Otolaryngology-Head and Neck Surgery, and sits on several other editorial boards. His work continues to shape international standards in head and neck pathology diagnosis.
Prof. Abbas Agaimy
Professor Abbas Agaimy is Professor and Deputy Director at the Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital, in Erlangen, Germany. He has been recognised as one of the top 2% most-cited scientists globally in pathology for 2022, 2023, and 2024, with over 700 PubMed-listed publications and contributions to more than 40 book chapters, including over 30 chapters in the WHO classification of tumours across multiple organ systems.
He is currently Editor-in-Chief of Virchows Archiv, the European Journal of Pathology, and serves on the editorial boards of leading journals including Modern Pathology, American Journal of Surgical Pathology, and Histopathology. His research interests span head and neck cancer, mesenchymal GI tumours, pancreatobiliary cancer, soft tissue tumours and sarcoma, melanoma, and hereditary tumour syndromes.
Prof. Martin Forster
Professor Martin Forster is a Professor at UCL and Consultant Medical Oncologist at University College Hospital, specialising in thoracic and head and neck cancers, with a particular interest in drug development and using cancer biology to design studies that identify which patients are most likely to benefit from new drugs and drug combinations.
He is a core member of the lung and head and neck cancer teams, and has served as principal or chief investigator for more than 50 early and late-phase clinical trials, ranging from first-in-human studies to registration Phase III trials. He is joint lead for the clinical trials theme of the Cancer Research UK Lung Cancer Centre of Excellence and chairs the NIHR Head and Neck Research Group.
Prof. Edward Odell
Professor Edward Odell is Professor of Oral Pathology and Medicine at King's College London and Honorary Consultant in Histopathology at Guy's and St Thomas' NHS Foundation Trust, where he previously served as Clinical Lead for Head and Neck Pathology. He has special interests in oral carcinoma and precancer, molecular oncology of oral precancer, sentinel node biopsy, and odontogenic tumours.
He has published over 180 peer-reviewed papers and is the author of several standard textbooks in head and neck disease, including contributions as an author to the 2005 and 2017 WHO Classification of Head and Neck Tumours. He has particular expertise in image-based ploidy analysis for predicting cancer development in the upper digestive tract, and runs the only routine pathology service for this test in the UK.
Dr. Ian Proctor
Dr Ian Proctor is a Consultant Histopathologist at University College London Hospitals NHS Foundation Trust, specialising in haematopathology and head and neck pathology. Prior to this role, he was a Clinical Lecturer in the Academic Department of Pathology at UCLH from 2008 to 2013, and a Specialist Registrar there from 2006 to 2008.
He is a member of the Pathological Society of Great Britain and Ireland, the UK Endocrine Society, and the British Lymphoma Pathology Group, and has previously served as Clinical Audit Lead for Histopathology at UCLH. His research contributions include work on cancer evolution as part of the TRACERx Renal Consortium.
Dr. Fernanda Amary
Dr Fernanda Amary is a Consultant Histopathologist at the Royal National Orthopaedic Hospital, where she serves as Laboratory Director, and an Honorary Associate Professor of Pathology at University College London. Her specialist focus is bone and soft tissue pathology, with a particular interest in the molecular genetics of sarcomas.
She qualified from Santa Casa Medical School in São Paulo, Brazil, in 1994, and completed her MPhil in 2001 and PhD in 2007. She moved to the UK in 2010 to take up her consultant post at the Royal National Orthopaedic Hospital, and was appointed Honorary Senior Lecturer at UCL in 2011. She has published extensively on the molecular characterisation of bone and soft tissue tumours.